Cardiac Autonomic Neuropathy Testing
One of the most overlooked of all serious complications of diabetes is cardiovascular autonomic neuropathy (CAN) which encompasses damage to the autonomic nerve fibers that innervate the heart and blood vessels, resulting in abnormalities in heart rate control and vascular dynamics.
The CAN is a common form of diabetic autonomic neuropathy and causes abnormalities in heart rate control as well as central and peripheral vascular dynamics.
The clinical manifestations of CAN include exercise intolerance, intraoperative cardiovascular lability, orthostatic hypotension, painless myocardial ischemia, and increased risk of mortality.
The present report discusses the clinical manifestations (eg, resting tachycardia, orthostasis, exercise intolerance, intraoperative cardiovascular liability, silent myocardial infarction [MI], and increased risk of mortality) in the presence of cardiovascular autonomic neuropathy (CAN).
Cardiac Autonomic Neuropathy Testing
CAN contributes to morbidity, mortality, and reduced quality of life for persons with diabetes. The American Diabetes Association has recently published a statement that provides guidelines for prevention, detection, and management of neuropathy, including CAN, for healthcare providers who care for patients with diabetes.
It also demonstrates that autonomic dysfunction can affect daily activities of individuals with diabetes and may invoke potentially life-threatening outcomes.
Algorithms for the evaluation and treatment of the patient with CAN, even if the patient is asymptomatic, are provided in this review.
Cardiac Autonomic Neuropathy Testing, cardiac autonomic neuropathy, diabetic autonomic neuropathy manufacturers and suppliers in India.
For more details please visit http://www.diabetikfootcare.com/cardiac_autonomic_neuropathy_testing.php
One of the most overlooked of all serious complications of diabetes is cardiovascular autonomic neuropathy (CAN) which encompasses damage to the autonomic nerve fibers that innervate the heart and blood vessels, resulting in abnormalities in heart rate control and vascular dynamics.
The CAN is a common form of diabetic autonomic neuropathy and causes abnormalities in heart rate control as well as central and peripheral vascular dynamics.
The clinical manifestations of CAN include exercise intolerance, intraoperative cardiovascular lability, orthostatic hypotension, painless myocardial ischemia, and increased risk of mortality.
The present report discusses the clinical manifestations (eg, resting tachycardia, orthostasis, exercise intolerance, intraoperative cardiovascular liability, silent myocardial infarction [MI], and increased risk of mortality) in the presence of cardiovascular autonomic neuropathy (CAN).
Cardiac Autonomic Neuropathy Testing
CAN contributes to morbidity, mortality, and reduced quality of life for persons with diabetes. The American Diabetes Association has recently published a statement that provides guidelines for prevention, detection, and management of neuropathy, including CAN, for healthcare providers who care for patients with diabetes.
It also demonstrates that autonomic dysfunction can affect daily activities of individuals with diabetes and may invoke potentially life-threatening outcomes.
Algorithms for the evaluation and treatment of the patient with CAN, even if the patient is asymptomatic, are provided in this review.
Cardiac Autonomic Neuropathy Testing, cardiac autonomic neuropathy, diabetic autonomic neuropathy manufacturers and suppliers in India.
For more details please visit http://www.diabetikfootcare.com/cardiac_autonomic_neuropathy_testing.php
Dear Mr. Elango!
ReplyDeleteCan you provide thermal (like Harris Mat) sensor for detecting possible areas of inflammation in diabetic foot?
In Cardiac Autonomic Neuropathy Testing, They are usually accompanied by somatic neuropathy but can be autonomic only.
ReplyDelete